Pharmaceutical Preparations · A1 · CIK 1703057
AbCellera discovers antibodies for drug development partners, generating revenue from upfront and downstream payments
Comparable business profile · signals at a glance
In the 90 days to Feb 27, 2026: 2 insiders bought $857K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Booth AndrewChief Financial Officer | Buy | 42,600 | $3.42 | $146K |
| Feb 27, 2026 | Thermopylae Holdings Ltd.TenPercentOwner | Buy | 38,000 | $3.44 | $131K |
| Feb 26, 2026 | Thermopylae Holdings Ltd.TenPercentOwner | Buy | 177,457 | $3.27 | $580K |
| Nov 26, 2025 | Montalbano John S.Director | Buy | 50,000 | $3.57 | $179K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.